A.R.T. Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,130	Closed	-$2.15M	–	38
2019 Q4	$2.15M	Buy	50,130 +28,700	+134%	+$1.25M	0.11%	273
2019 Q3	$771K	Sell	21,430 -100	-0.5%	-$3.03K	0.04%	671
2019 Q2	$575K	Sell	21,530 -30,100	-58%	-$769K	0.03%	693
2019 Q1	$1.39M	Buy	+51,630	New	+$1.21M	0.08%	360
2018 Q3	–	Sell	-91,230	Closed	-$1.39M	–	1365
2018 Q2	$1.39M	Buy	+91,230	New	+$1.63M	0.06%	490
2018 Q1	–	Sell	-59,605	Closed	-$1.79M	–	1463
2017 Q4	$1.79M	Buy	+59,605	New	+$1.91M	0.08%	406
2017 Q1	–	Sell	-12,100	Closed	-$348K	–	1391
2016 Q4	$348K	Buy	+12,100	New	+$320K	0.02%	888
2016 Q2	–	Sell	-155,645	Closed	-$4.35M	–	1317
2016 Q1	$4.35M	Buy	155,645 +148,208	+1,993%	+$3.23M	0.19%	125
2015 Q4	$265K	Sell	7,437 -86,032	-92%	-$3.03M	0.01%	1099
2015 Q3	$3.09M	Buy	+93,469	New	+$3.89M	0.11%	245
2015 Q1	–	Sell	-11,788	Closed	-$374K	–	1392
2014 Q4	$374K	Buy	+11,788	New	+$334K	0.01%	1022